thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN Open Vial: Do Not Worry About its Wastage

COVID Vaccines

COVAXIN Open Vial: Do Not Worry About its Wastage

TheNewsFacts
Last updated: December 20, 2021 8:40 pm
TheNewsFacts
Share
COVAXIN Open Vial: Do Not Worry About its Wastage
SHARE

Bharat Biotech, India’s indigenous vaccine maker noted that health care workers do not have to worry about COVAXIN Open Vial and its wastage. If a vaccine administration sites are find that there are not enough patients, they can simply store the opened vial at 2 to 8°C, and use it in the subsequent day or store it for up to 28 days, Bharat Biotech noted.

Check out 4 things to note about COVAXIN Open Vial Policy

COVAXIN open vial policy
Covaxin Open Vial Policy Explained

This details given below clearly means that an open COVAXIN vial can be used up to 28 days post opening and would not go to waste if there no patients immediately available.

1 ) COVAXIN®️ Open Vial is stable at 2 to 8°C for 28 days

Opened vial of COVAXIN®️ , can be stored at 2-8°C for up to 28 days and not required to be discarded immediately in a day or at the end of immunisation session.

2 ) 20 Dose vial

We believe in doing our bit to care for our environment, the multi dose vial policy saves money for procurement agencies by reducing the cold chain logistics and management. Thereby reducing the carbon footprint, costs related to open vial wastage, cold chain distribution, cold chain storage, biomedical waste disposal etc.

3 ) Eco-Friendly

Most importantly, we believe in being environmentally friendly by reducing the quantum of packing materials and single use plastics that are utilized in vaccines manufacturing, storage, distribution and disposal.

4 )COVAXIN®️ Shelf life upto 12 Months

COVAXIN®️ is approved for use under the 28-day multi-dose vial policy from Drugs Controller General of India and the WHO Emergency Use Listing (WHO EUL). The CDSCO has recently approved the extension of COVAXIN®️ shelf life upto 12 months from the date of manufacture.

This approval of shelf-life extension is based on the availability of additional stability data, which was submitted to CDSCO. With the shelf-life extension, hospitals can now utilize the stock which was nearing the expiry and avoid vaccine wastage.

TAGGED:BHARAT BIOTECH COVAXINBHARAT BIOTECH NEWSCovaxinCovaxin NewsCOVAXIN VIAL
Share This Article
Email Copy Link Print
Previous Article Decoupled Review: A perfect dose of truth, dealt with fun Decoupled Review: A perfect dose of truth, dealt with fun
Next Article Now Angry Young Man's Wife Jaya Bachchan turns Angry - Why? Now Angry Young Man’s Wife Jaya Bachchan turns Angry – Why?

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

World Crisis Today: Climate and Inequality at unsustainable levels – UN

United Nations stated on Tuesday Inequality is at unsustainable levels as the net worth of some…

By
TheNewsFacts

Kayne West says call me ‘Ye’ from now on

Kayne West now says call me 'Ye' , that is the new name of Kanye…

By
TheNewsFacts

Analyzing Shreyas Iyer, the Middle Order Clash at the CWC 23 Semi-Final

As the semi-final clash between India and New Zealand looms on November 15th, the spotlight…

By
NewsFacts Bureau

You Might Also Like

iNCOVACC: Bharat Biotech Reveals World's 1st Nasal COVID Vaccine Price
COVID Vaccines

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

By
TheNewsFacts
Bharat Biotech Nasal Vaccine as Covid booster dose, first in Hospitals: Govt
COVID Vaccines

Bharat Biotech Nasal Vaccine as Covid Booster Dose, First in Hospitals: Govt

By
TheNewsFacts
Big News of the Day: India's COVAXIN Gets Regular Market Approval from DCGI
COVID Vaccines

India’s COVAXIN Gets Regular Market Approval

By
TheNewsFacts
COVAXIN Maker Bharat Biotech Intranasal Vaccine (BBV154) Approved for Phase 3 Clinical Trials
COVID Vaccines

COVAXIN Maker Bharat Biotech Intranasal Vaccine (BBV154) Approved for Phase 3 Clinical Trials

By
TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?